Chemed (CHE) Fundamental Analysis: Revenue, Earnings & Valuation

8.86 / 10

Outperform

Fundamentally, Chemed scores Outperform with an 8.9/10 quality. Strong cash metrics (Cash‑MV, Cash‑UP) and high inventory turnover boost its rating, though cash‑flow growth and earnings YoY are weak, limiting upside.

Analysis Checks(5/10)

Revenue-MV

Value-0.05

Score0/3

Weight-17.55%

1M Return-4.84%

Net cash flow from operating activities per share (YoY growth rate %)

Value-1.26

Score0/3

Weight-8.42%

1M Return-2.26%

Inventory turnover ratio

Value216.93

Score3/3

Weight45.03%

1M Return7.73%

Net income-Revenue

Value-0.03

Score3/3

Weight47.49%

1M Return7.62%

Basic earnings per share (YoY growth rate %)

Value-8.36

Score1/3

Weight4.81%

1M Return0.92%

Total profit (YoY growth rate %)

Value-10.94

Score2/3

Weight16.05%

1M Return3.08%

Net cash flow from operating activities (YoY growth rate %)

Value-7.00

Score0/3

Weight-10.41%

1M Return-2.67%

Cash-UP

Value0.26

Score2/3

Weight5.55%

1M Return0.89%

Diluted earnings per share (YoY growth rate %)

Value-7.79

Score1/3

Weight4.01%

1M Return0.78%

Cash-MV

Value-0.16

Score2/3

Weight13.45%

1M Return2.77%

Is CHE undervalued or overvalued?

CHE scores 8.86/10 on fundamentals and holds a Discounted valuation at present. Backed by its 25.28% ROE, 10.48% net margin, 19.41 P/E ratio, 5.26 P/B ratio, and -8.36% earnings growth, these metrics solidify its Outperform investment rating.